News

Access Physical Therapy Expands with Strategic Acquisition in NY

Access Physical Therapy Expands with Strategic Acquisition in NY

Access Physical Therapy & Wellness Welcomes New Partnership

Access Physical Therapy & Wellness is excited to announce its recent acquisition of Physical Therapy Associates of Schenectady. This strategic partnership will significantly enhance patient care across the regions served by both entities.

A Legacy of Care

Physical Therapy Associates of Schenectady has established itself as a trusted provider of physical therapy services, operating since 1982. Their commitment to quality patient care aligns perfectly with the mission of Access Physical Therapy & Wellness to deliver outstanding healthcare.

Enhanced Services and Resources

The acquisition allows PTAS to maintain its stellar patient care while gaining access to a suite of management services offered by Confluent Health. These services include comprehensive talent development, business intelligence tools, and clinic optimization resources, which will help employ best practices and streamline operations. By leveraging these resources, PTAS aims to enhance the support available to their clinical teams, ensuring continued exceptional patient outcomes.

Expanding Access and Footprint

This merger will unite both organizations under a shared vision of providing high-quality, patient-centered care. With this partnership, Access Physical Therapy will now operate 73 clinics across several states, significantly enhancing their footprint. This includes locations in Connecticut, Massachusetts, New York, North Carolina, and Pennsylvania, allowing for broader access to care for more patients.

Commitment to Patient-Centered Care

Christopher Albanese, PT, MS, Co-Founder and Co-CEO of ACCESS PT, expressed his excitement regarding the partnership, stating, "We are honored to partner with a practice that has served the community so well. Together, we can build on their legacy while providing enhanced resources, ensuring our patients receive the best care possible. This collaboration reflects our dedication to patient-centric services and professional development.”

Access to Innovative Tools

As part of the partnership, PTAS will gain access to various innovative tools and platforms, such as the hybrid care platform named m?viHealth and the PTPN network. Furthermore, employees will benefit from the numerous continuing education courses offered through Evidence in Motion and safety solutions from Fit For Work. This collection of resources demonstrates the focus on elevating service quality and optimizing patient care.

A Bright Future Ahead

Ed Miersch, Senior Vice President of Outpatient Rehab Companies, stated, "This partnership solidifies our commitment to patient-centered care. We are eager to support the Physical Therapy Associates of Schenectady team with new tools and resources that will foster their growth. This shared commitment to quality care makes us an ideal match.”

About Access Physical Therapy

Access Physical Therapy and Wellness positively impacts patients' lives by delivering superior care through innovative treatments and technologies. It is heavily focused on research-based practices that prioritize the well-being of patients, treating each one like family. As a part of the Confluent Health Family, ACCESS PT continues to expand its positive influence on the communities it serves.

About Confluent Health

Confluent Health is a leader in advancing musculoskeletal solutions, focusing on delivering better patient outcomes while also improving workplace wellness. Their network of physical and occupational therapy companies emphasizes education, injury prevention, and industry best practices.

Frequently Asked Questions

What motivated Access Physical Therapy to acquire PTAS?

The acquisition is aimed at enhancing patient care and expanding services while leveraging additional resources offered by Confluent Health.

How will this acquisition impact PTAS patients?

PTAS patients will continue to receive the same high-quality care while benefiting from enhanced resources and support for their clinical teams.

What resources will PTAS gain from Access Physical Therapy?

PTAS will have access to management services, talent development, business intelligence tools, and innovative platforms like m?viHealth.

How many clinics will Access Physical Therapy operate after this acquisition?

Access Physical Therapy will operate a total of 73 clinics across several states after the acquisition.

What is the mission of Access Physical Therapy?

The mission of Access Physical Therapy is to deliver the best care and results through innovative treatment and a patient-centered approach.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

U Power Limited Advances Electric Vehicle Solutions in Europe

Updated Category News Views 239

U Power Limited Expands Its European Reach U Power Limited (Nasdaq: UCAR) is making significant strides in the electric vehicle (EV) landscape. The company, known for its innovative battery-swapping technology, has announced an exciting joint venture that enhances their presence in the European market. This strategic move is expected to reshape how electric mobility is...

Continue Reading
UKG Stands Out as a Top Leader in Workforce Management Solutions

Updated Category News Views 163

UKG Secures Top Spot in Workforce Management UKG, a leading provider in HR, payroll, workforce management, and cultural solutions, has recently earned recognition for its exceptional contributions to the workforce management field. The company has been named a Leader in the NelsonHall New World Workforce Management 2024 evaluation, showcasing its strong performance across...

Continue Reading
Prominent Movers in Today's Market: Micron, Accenture Rise

Updated Category News Views 141

As the trading day unfolds, the US stock market is witnessing a shift, with several companies experiencing significant movements in their stock prices. Recent trends show that investors are closely monitoring the market after a minor disruption in gains. Micron's Robust Performance Micron Technology (NASDAQ: MU) has captured the spotlight today, with shares surging by an...

Continue Reading
Celebrate 1.5 Years of Obey Me! Nightbringer with Exciting Events

Updated Category News Views 85

Celebrating 1.5 Years of Obey Me! Nightbringer Obey Me! Nightbringer is reaching a significant milestone, celebrating its 1.5-year anniversary. This beloved mobile game from NTT Solmare has captured the hearts of players around the globe, and to acknowledge this momentous occasion, the developers are rolling out a variety of exciting events. Four Exciting Events for...

Continue Reading
Celebrating Innovation: 2026 sofi™ Awards Winners Unveiled

Updated Category News Views 219

Celebrating Culinary Excellence: The 2026 sofi™ Awards NEW YORK — The Specialty Food Association (SFA) revealed the much-anticipated results of the 2026 sofi™ Awards at the Winter FancyFaire event. This celebrated gathering brought together industry leaders, chefs, makers, and buyers to applaud the finest in specialty food and beverage innovation. A Night of...

Continue Reading